Cite

HARVARD Citation

    Rosenbaum, E. et al. (2019). A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor. Oncologist. pp. 1309-e983. [Online]. 
  
Back to record